Table 1.
Author-year | Country | Cancer type | Method | Genotype (N) | P HWE controls | |||||
---|---|---|---|---|---|---|---|---|---|---|
Case | Control | |||||||||
CC | CA | AA | CC | CA | AA | |||||
Lei et al. 2002 | Swiss | Breast | PCR-SSCP | 226 | 166 | 32 | 135 | 92 | 21 | 0.350 |
Lei et al. 2002 | Czech | Breast | PCR-SSCP | 74 | 60 | 18 | 51 | 42 | 7 | 0.677 |
Cattaneo et al. 2006 | Italy | Breast | PCR-RFLP | 50 | 43 | 6 | 139 | 89 | 18 | 0.476 |
Yu et al. 2006 | China | Breast | Taqman | 222 | 201 | 44 | 243 | 187 | 39 | 0.721 |
Tipirisetti et al. 2013 | India | Breast | Sequencing | 120 | 26 | 56 | 175 | 42 | 33 | <0.001 |
PCR-SSCP Polymerase chain reaction single-strand conformation polymorphism, RFLP restriction fragment length polymorphism